首页> 外文期刊>European journal of organic chemistry >Synthesis of novel macrolactam and macroketone analogues of migrastatin from D-glucal and comparison with macrolactone and acyclic analogues: A dorrigocin A congener is a potent inhibitor of gastric cancer cell migration
【24h】

Synthesis of novel macrolactam and macroketone analogues of migrastatin from D-glucal and comparison with macrolactone and acyclic analogues: A dorrigocin A congener is a potent inhibitor of gastric cancer cell migration

机译:从D-葡糖醛中合成偏头痛素的新型大内酰胺和大酮类似物,并与大内酯和无环类似物进行比较:阿雷戈星A同系物是胃癌细胞迁移的有效抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Novel macrolactam and macroketone analogues of the migrastatin macrolide core have been synthesised from tri-O-acetyl-D-glucal in order to facilitate structure-activity studies. The Horner olefination, followed by ring-closing metathesis were key steps in the synthesis of the macroketone. The ability of the macroketone and macrolactam derivatives to inhibit the migration of gastric tumour cells as determined using a transwell migration assay were compared with macrolactone analogues and dorrigocin A analogues. One dorrigocin A congener was the most potent inhibitor of gastric cancer cell migration. ((C) Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008).
机译:为了促进结构活性研究,已经从三-O-乙酰基-D-葡糖醛合成了偏头痛他汀大环内酯核心的新型大内酰胺和大酮类似物。霍纳烯化反应,然后进行闭环复分解反应是合成大酮的关键步骤。将大酮和大内酰胺衍生物抑制胃肿瘤细胞迁移的能力,如使用跨孔迁移测定法所确定的,与大内酯类似物和多瑞戈霉素A类似物进行了比较。一种dorrigocin A同源物是最有效的胃癌细胞迁移抑制剂。 ((C)Wiley-VCH Verlag GmbH&Co.KGaA,69451 Weinheim,Germany,2008)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号